國新健康(000503.SZ):控股股東所持1600萬股解凍
格隆匯11月27日丨國新健康(000503.SZ)公佈,公司於2019年11月27日接到控股股東中海恆通知,關於張文山、張文益與中海恆的委託合同糾紛一案,經海南省高級人民法院主持調解,原、被告達成協議。根據《中華人民共和國海南省高級人民法院民事調解書(2018)瓊民初7號》,中海恆已於2019年9月30日支付第二筆和解款項1.56億元至海南省高級人民法院賬户。
經查詢,中海恆因本案被海南省高級人民法院凍結的3938.1040萬股公司股票中的1600萬股股票解除司法凍結相關手續已於2019年11月26日在中國證券登記結算有限責任公司完成。
截至目前,中海恆持有公司股份2.3570億股,佔公司總股本的26.22%;累計被凍結1138.1040萬股,佔其所持股份的4.83%,佔公司總股本的1.27%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.